Total Payments
$2,245
2024 Payments
$315.37
Companies
20
Transactions
46
Medicare Patients
2,586
Medicare Billing
$173,925
Payment Breakdown by Category
Food & Beverage$1,451 (64.6%)
Education$443.89 (19.8%)
Consulting$350.00 (15.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,451 | 39 | 64.6% |
| Education | $443.89 | 6 | 19.8% |
| Consulting Fee | $350.00 | 1 | 15.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $359.55 | 7 | $0 (2024) |
| Medimetriks Pharmaceuticals, Inc. | $350.00 | 1 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $329.34 | 3 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $280.68 | 9 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $207.42 | 2 | $0 (2019) |
| TARO PHARMACEUTICALS USA, INC. | $158.35 | 2 | $0 (2017) |
| AbbVie Inc. | $125.52 | 3 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $99.99 | 1 | $0 (2022) |
| GENZYME CORPORATION | $95.67 | 5 | $0 (2022) |
| Journey Medical Corporation | $50.59 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $315.37 | 8 | E.R. Squibb & Sons, L.L.C. ($221.70) |
| 2023 | $553.01 | 9 | Medimetriks Pharmaceuticals, Inc. ($350.00) |
| 2022 | $157.96 | 4 | SANOFI-AVENTIS U.S. LLC ($99.99) |
| 2021 | $33.78 | 2 | AbbVie Inc. ($18.78) |
| 2020 | $60.49 | 4 | GENZYME CORPORATION ($22.70) |
| 2019 | $231.27 | 5 | Ortho Dermatologics, a division of Bausch Health US, LLC ($107.42) |
| 2018 | $218.28 | 3 | Janssen Scientific Affairs, LLC ($106.28) |
| 2017 | $675.16 | 11 | Janssen Scientific Affairs, LLC ($223.06) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.16 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $72.00 | General |
| Category: Immunology | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.84 | General |
| Category: Immunology | ||||||
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| Category: Immunology | ||||||
| 07/24/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: ANTIBIOTIC | ||||||
| 05/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $29.74 | General |
| Category: Immunology | ||||||
| 04/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.23 | General |
| Category: Immunology | ||||||
| 03/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $141.27 | General |
| Category: Immunology | ||||||
| 10/09/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.69 | General |
| Category: Immunology | ||||||
| 08/10/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.23 | General |
| Category: Immunology | ||||||
| 08/07/2023 | Medimetriks Pharmaceuticals, Inc. | TOVET (EMOLLIENT FORMULATION) (Drug) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: Dermatology | ||||||
| 08/07/2023 | ANI Pharmaceuticals, Inc. | ApexiCon E (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Treatment of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses | ||||||
| 06/01/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $64.95 | General |
| Category: Immunology | ||||||
| 04/13/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.06 | General |
| Category: Immunology | ||||||
| 03/15/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Immunology | ||||||
| 03/13/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: DERMATOLOGY | ||||||
| 01/20/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2022 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 02/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Immunology | ||||||
| 01/31/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Immunology | ||||||
| 01/14/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Immunology | ||||||
| 11/02/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: IMMUNOLOGY | ||||||
| 06/08/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Immunology | ||||||
| 11/30/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: Immunology | ||||||
| 08/31/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 655 | 1,707 | $153,932 | $47,886 |
| 2022 | 8 | 686 | 1,827 | $136,181 | $49,694 |
| 2021 | 9 | 683 | 1,724 | $118,608 | $44,492 |
| 2020 | 6 | 562 | 1,324 | $93,719 | $31,853 |
Total Patients
2,586
Total Services
6,582
Medicare Billing
$173,925
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 166 | 273 | $36,309 | $16,428 | 45.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 196 | 359 | $48,824 | $14,465 | 29.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 43 | 49 | $12,250 | $3,952 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 51 | $9,996 | $3,943 | 39.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 148 | 903 | $31,605 | $3,825 | 12.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $5,940 | $2,344 | 39.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 12 | 26 | $5,824 | $1,824 | 31.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 16 | 16 | $3,184 | $1,106 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 279 | $37,107 | $17,294 | 46.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 205 | 378 | $51,408 | $15,510 | 30.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 163 | 990 | $13,833 | $4,549 | 32.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 41 | 45 | $11,250 | $4,032 | 35.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 16 | 41 | $9,184 | $3,158 | 34.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $5,346 | $2,311 | 43.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 40 | 44 | $3,476 | $1,549 | 44.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 20 | 23 | $4,577 | $1,291 | 28.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 191 | 334 | $45,424 | $13,609 | 30.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 153 | 228 | $18,012 | $8,522 | 47.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 93 | $12,369 | $6,641 | 53.7% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 49 | 55 | $13,750 | $4,762 | 34.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 153 | 935 | $11,220 | $4,305 | 38.4% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 17 | 29 | $6,496 | $2,388 | 36.8% |
| 11603 | Removal of malignant growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs | Office | 2021 | 11 | 11 | $4,521 | $2,126 | 47.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 23 | 24 | $4,776 | $1,500 | 31.4% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 15 | 15 | $2,040 | $636.74 | 31.2% |
About Dr. Robert Debellevue, MD
Dr. Robert Debellevue, MD is a Dermatology healthcare provider based in Kenner, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245222595.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Debellevue, MD has received a total of $2,245 in payments from pharmaceutical and medical device companies, with $315.37 received in 2024. These payments were reported across 46 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,451).
As a Medicare-enrolled provider, Debellevue has provided services to 2,586 Medicare beneficiaries, totaling 6,582 services with total Medicare billing of $173,925. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Kenner, LA
- Active Since 08/22/2005
- Last Updated 02/24/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245222595
Products in Payments
- TOVET (EMOLLIENT FORMULATION) (Drug) $350.00
- STELARA (Biological) $322.06
- Sotyktu (Drug) $280.68
- Tremfya (Drug) $199.23
- DUPIXENT (Biological) $195.66
- TREMFYA (Drug) $163.96
- ALTRENO (Drug) $107.42
- Humira (Biological) $106.74
- SILIQ (Drug) $100.00
- Topicort Spray 0.25% (Drug) $79.18
- Topicort (Drug) $79.17
- TARGADOX (Drug) $50.59
- ApexiCon E (Drug) $27.52
- NUZYRA (Drug) $21.67
- ADBRY (Biological) $20.77
- SKYRIZI (Biological) $18.78
- DUPIXENT DUPILUMAB INJECTION (Biological) $17.29
- Hylatopic (Drug) $15.91
- KERYDIN (Drug) $15.00
- LIBTAYO (Biological) $13.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.